title: Danazol-induced hepatocellular adenoma.
authors.affiliation: Service d'Immuno-Hématologie, Hôpital Saint Louis, Paris, France.
authors.forename: J P
authors.initials: JP
authors.lastname: Fermand
authors.forename: Y
authors.initials: Y
authors.lastname: Levy
authors.forename: D
authors.initials: D
authors.lastname: Bouscary
authors.forename: M F
authors.initials: MF
authors.lastname: D'Agay
authors.forename: P
authors.initials: P
authors.lastname: Clot
authors.forename: J
authors.initials: J
authors.lastname: Frija
authors.forename: J C
authors.initials: JC
authors.lastname: Brouet
mesh_terms: D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced*; D003613:Danazol / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000139:chemically induced*; D011245:Pregnadienes / Q000009:adverse effects*; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy
chemical_list: D011245:Pregnadienes; D003613:Danazol